Status | Study |
Recruiting |
Study Name: New Strategies to Assess Anal Cancer Risk In Women Condition: Human Immunodeficiency Virus (HIV) Human Papillomavirus (HPV) Date: 2016-08-17 Interventions: Procedure: Perianal and Digital Anorectal Exam |
Recruiting |
Study Name: E7 TCR T Cells With or Without PD-1 Blockade for Human Papillomavirus-Associated Cancers Condition: Cervical Cancer Vaginal Cancer Anal Date: 2016-08-04 Interventions: Biological: E7 TCR Transduced PBL cells |
Withdrawn |
Study Name: A Prospective, Open-Label, Multi-center Comparison of Lymphoseek Identified Lymph Nodes and Clinically Identified Lymph Nodes of Subjects With Known Cancer of the Anus Condition: Anal Cancer Date: 2016-08-02 Interventions: Drug: Lymphoseek |
Recruiting |
Study Name: Trial To Test Safety And Efficacy Of Vaccination For Incurable HPV 16-Related Oropharyngeal, Cervical And Anal Cancer Condition: Cancer of Head and Neck Cancer of Cervix Date: 2016-07-14 Interventions: Drug: DPX-E7 vaccine Therapeut |
Enrolling by invitation |
Study Name: Validation of a Health-Related Symptom Index for Persons Diagnosed With and Either Treated or Monitored for Anal High-Grade Squamous Intraepithelial Lesions (HSIL) Condition: Anal High-Grade Squamous Intraepithelial Lesions Date: 2016-07-12 Interventions: Behavioral: Assessment of Health-Related Quality Demographic Questionnaire, ANCHOR HRSI, FACT-G, MDASI, |
Recruiting |
Study Name: Anal Cytology Collection Procedures in Predicting High-Grade Anal Dysplasia in Men Who Have Sex With Men Condition: Anal Carcinoma HIV Infection Date: 2016-05-23 Interventions: Procedure: Cytology Specimen Collection Procedure |
Recruiting |
Study Name: Shared Decision Making With Anal Cancer Patients on Radiation Dose Condition: Anal Cancer Date: 2016-05-09 Interventions: Radiation: 2.15 gray and 1.8 gray. Max. 6 weeks. |
Not yet recruiting |
Study Name: A Phase I Study of Photodynamic Therapy (PDT) for High-grade Anal Dysplasia and Microinvasive Anal Cancer Condition: Anal Cancer Date: 2016-03-01 Interventions: Drug: Gliolan orally, 40 mg/kg |
Recruiting |
Study Name: Individual Following in Anal Cancer With PET/CT Condition: Anal Cancer Date: 2016-02-22 Interventions: Other: anal cancer Anal cancer patients with TEP TDM |
Recruiting |
Study Name: Study of SIB-IMRT in Combination With 5-FU and Mitomycin-C Among Patients With Locally Advanced Anal Canal Cancer: Efficacy, Safety and Quality of Life Condition: Locally Advanced Anal Canal Cancer Date: 2015-12-23 Interventions: Drug: 5Fluorouracile and Mitomycin-C |